Concord Biotech Limited (NSE:CONCORDBIO)
India
· Delayed Price · Currency is INR 1,525.00
+2.00 (0.13%)
May 9, 2025, 3:29 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 161.49 billion as of May 9, 2025. Its market cap has decreased by -3.10% in one year.
Market Cap
161.49B
Enterprise Value
158.68B
Revenue
10.89B
Ranking
n/a
PE Ratio
49.49
Stock Price
1,525.00
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 161.49B, an increase of 63.73%. That is a compound annual growth rate of 33.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 161.49B | -30.18% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,240.10B |
| Divi's Laboratories | 1,582.33B |
| Cipla | 1,200.80B |
| Mankind Pharma | 1,006.49B |
| Apollo Hospitals Enterprise | 985.14B |
| Zydus Lifesciences | 879.15B |
| Aurobindo Pharma | 672.34B |
| Alkem Laboratories | 590.59B |